- Home
- OBIO vs OPOF Comparison
OBIO vs OPOF Comparison
Compare OBIO & OPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- OPOF
- Stock Information
- Founded
- OBIO 2017
- OPOF 1922
- Country
- OBIO United States
- OPOF United States
- Employees
- OBIO N/A
- OPOF N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- OPOF Major Banks
- Sector
- OBIO Health Care
- OPOF Finance
- Exchange
- OBIO Nasdaq
- OPOF Nasdaq
- Market Cap
- OBIO 156.6M
- OPOF 127.2M
- IPO Year
- OBIO N/A
- OPOF N/A
- Fundamental
- Price
- OBIO $5.28
- OPOF $25.10
- Analyst Decision
- OBIO Strong Buy
- OPOF
- Analyst Count
- OBIO 5
- OPOF 0
- Target Price
- OBIO $15.80
- OPOF N/A
- AVG Volume (30 Days)
- OBIO 182.8K
- OPOF 5.0K
- Earning Date
- OBIO 11-12-2024
- OPOF 01-28-2025
- Dividend Yield
- OBIO N/A
- OPOF 2.23%
- EPS Growth
- OBIO N/A
- OPOF N/A
- EPS
- OBIO N/A
- OPOF 1.60
- Revenue
- OBIO $2,647,000.00
- OPOF $59,503,000.00
- Revenue This Year
- OBIO $22.61
- OPOF N/A
- Revenue Next Year
- OBIO $16.64
- OPOF N/A
- P/E Ratio
- OBIO N/A
- OPOF $15.64
- Revenue Growth
- OBIO N/A
- OPOF N/A
- 52 Week Low
- OBIO $3.96
- OPOF $13.49
- 52 Week High
- OBIO $10.06
- OPOF $28.00
- Technical
- Relative Strength Index (RSI)
- OBIO 50.69
- OPOF 56.36
- Support Level
- OBIO $5.00
- OPOF $24.90
- Resistance Level
- OBIO $5.70
- OPOF $25.40
- Average True Range (ATR)
- OBIO 0.57
- OPOF 0.64
- MACD
- OBIO 0.05
- OPOF -0.22
- Stochastic Oscillator
- OBIO 56.41
- OPOF 17.14
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About OPOF Old Point Financial Corporation
Old Point Financial Corp functions in the financial services domain in the United States. As the holding company of The Bank and Trust, it is a nationally chartered trust and wealth management service, provider. Its suite of services includes commercial banking solutions such as loan, deposit and cash management, which are rendered through a chain of branches throughout the country. It operates through segments such as Bank, Wealth and Company.